000 01187 a2200337 4500
005 20250510210839.0
264 0 _c19771229
008 197712s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(77)90905-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGalton, D A
245 0 0 _aInfection and second-remission rates in patients having immunotherapy for acute myeloid keukemia.
_h[electronic resource]
260 _bLancet (London, England)
_cNov 1977
300 _a973 p.
_bdigital
500 _aPublication Type: Comparative Study; Letter
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBCG Vaccine
_xtherapeutic use
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aHumans
650 0 4 _aInfections
_xepidemiology
650 0 4 _aLeukemia, Myeloid, Acute
_ximmunology
650 0 4 _aRemission, Spontaneous
700 1 _aKay, H E
700 1 _aReizenstein, P
700 1 _aPenchansky, M
700 1 _aVogler, W R
700 1 _aWhittaker, J A
773 0 _tLancet (London, England)
_gvol. 2
_gno. 8045
_gp. 973
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(77)90905-9
_zAvailable from publisher's website
999 _c70422
_d70422